Burden and Direct Costs of Non Infectious Uveitis in Spain
| Autor: | Antonio Bañares-Cañizares, Ricardo Blanco-Alonso, Esperanza Pato-Cour, Agustí Sellas-Fernández, José Benítez-del-Castillo, Alfredo Manuel Adán-Civera |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Uveitis Young Adult 03 medical and health sciences Indirect costs 0302 clinical medicine Pharmacotherapy Cost of Illness Internal medicine Epidemiology Health care medicine Humans 030212 general & internal medicine Young adult Aged business.industry Incidence (epidemiology) Health Care Costs General Medicine Middle Aged medicine.disease Surgery Spain 030221 ophthalmology & optometry Intermediate uveitis Female business |
| Zdroj: | Reumatología Clínica (English Edition). 12:196-200 |
| ISSN: | 2173-5743 |
| DOI: | 10.1016/j.reumae.2016.04.003 |
| Popis: | Objectives There is no updated information on epidemiology and cost of management of non infectious uveitis (NIU) in Spain. This study assessed the frequency of various types of uveitis as well as associated costs of resources used in their management. Material and method NIU epidemiological data and direct costs were collected from a literature search. This was complemented with consensus information from 2 expert panel meetings and data from questionnaires to ophthalmologists and rheumatologists, experts on these conditions. Healthcare resources costs were obtained from the Oblikue database, from a medical society and from approved drug prices in Spain. Results During 2011 the estimate number of NIU was 9398 (45% male, 70% aged 16–65 years). Incidence per type of uveitis was: acute anterior uveitis (AAU) 55%; posterior uveitis (PU) and pan-uveitis (PanU) 15% each; adult chronic anterior uveitis, pediatric chronic anterior uveitis and intermediate uveitis 5% each. Among total costs (77,834,282.10€), initial drug therapy was the highest (43,602,359.29€), followed by surgical treatment of complications (8,367,420.43€). With respect to types of uveitis, PanU (26,692,948.29€), PU (22,283,330.50€) and AAU (14,336,755.38€) showed the highest associated costs. Conclusions Non infectious uveitis is associated to high costs in Spain, both in its diagnosis and in its treatment. Early diagnosis and treatment should allow for substantial savings for the National Health System. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect